Real-time enrollment status for this solid tumors clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 10:59 PM UTC
| NCT Number | NCT07416123 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 103 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Genmab |
| Last Updated on CT.gov | August 12, 2026 (2 weeks ago) |
As of September 1, 2026: Clinical trial NCT07416123 is currently recruiting participants. This phase1 study for solid tumors is actively seeking new participants at 5 locations across the United States. The study is sponsored by Genmab. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07416123 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07416123 was last updated 2 weeks ago (August 12, 2026). HelloStudys verifies this status automatically.